Personalized Medicine — Current Affairs 2026

Current Affairs Connections

Recent developments and news linked to Personalized Medicine.

Indian DBT Launches 'GenomeIndia' Project Phase II to Map Diverse Indian Population Genomes

Early 2024 (Ongoing)

Building on initial efforts, the Department of Biotechnology (DBT) in India is expanding the 'GenomeIndia' project, aiming to sequence thousands more genomes from diverse ethnic groups across the country. This initiative is fundamental for personalized medicine in India, as it will create a comprehensive reference database of genetic variations specific to the Indian population. Such data is crucial for understanding disease susceptibility, drug response, and developing targeted therapies tailored for Indians, addressing the current reliance on predominantly Caucasian genomic data. This directly supports the 'personalized medicine UPSC' and 'personalized medicine current affairs' angles.

UPSC Angle: Government initiatives in science and technology, importance of genomic diversity in medical research, potential for indigenous drug development, data privacy and ethical implications of large-scale genomic data collection in India.

Background (2023)

Earlier events that provide context for this topic.

FDA Approves First CRISPR-Based Gene Therapy for Sickle Cell Disease

December 2023

The U.S. Food and Drug Administration (FDA) approved Casgevy, the first gene-editing therapy using CRISPR/Cas9 technology, for the treatment of sickle cell disease in patients 12 years and older. This marks a monumental step for personalized medicine, demonstrating the clinical viability of correcting genetic defects at their source. It exemplifies how advanced biotechnologies are moving from research labs to patient bedsides, offering curative potential for previously intractable genetic disorders. From a UPSC perspective, this highlights the rapid advancements in gene therapy and the ethical-regulatory challenges of bringing such transformative, yet expensive, treatments to a global population.

UPSC Angle: Technological breakthroughs in medical biotechnology, ethical considerations of gene editing, regulatory challenges for novel therapies, healthcare accessibility and cost implications for India.